Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Detection of patients at risk for developing integrin antagonist/agonist mediated disease states

Detection of patients at risk for developing integrin antagonist/agonist mediated disease states

US Patent 6623981 · Granted Sep 23, 2003

Estimated economic value: $45,066,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EPCAM binding fibronectin type III domains2025
Serum albumin-binding fibronectin type III domains and uses thereof2025
EGFR and C-met fibronectin type III domain binding molecules2025
Fibronectin type III domain based scaffold compositions, methods and uses2025
Anti-coagulation factor XI antibodies2025
FN3 domain-siRNA conjugates and uses thereof2025
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2024
Prostate specific membrane antigen binding fibronectin type iii domains2024
CD71 binding fibronectin type III domains2024
Serum albumin-binding fibronectin type III domains2023
FN3 domain-siRNA conjugates and uses thereof2023
Cysteine engineered fibronectin type III domain binding molecules2023